Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity

Doxorubicin hydrochloride (DOX) is a well-known antitumor drug used as first line treatment for many types of malignancies. Despite its clinical relevance, the administration of the compound is negatively affected by dose-dependent off-target toxicity phenomena. Nanotechnology has helped to overcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Voci, Silvia, Gagliardi, Agnese, Ambrosio, Nicola, Salvatici, Maria Cristina, Fresta, Massimo, Cosco, Donato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860592/
https://www.ncbi.nlm.nih.gov/pubmed/36678809
http://dx.doi.org/10.3390/pharmaceutics15010180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860592/
https://www.ncbi.nlm.nih.gov/pubmed/36678809
http://dx.doi.org/10.3390/pharmaceutics15010180

Ejemplares similares